Chemistry:DopAmide

From HandWiki

DopAmide, or L-DopAmide, is a synthetic levodopa (L-DOPA) analogue that can serve as a levodopa and dopamine prodrug and is of potential interest in the treatment of Parkinson's disease.[1][2][3] DopAmide has an amide rather than the carboxyl group of L-DOPA,[2][3] which imparts greater water solubility.[1][2][3] The amide is hydrolyzed back to the acid by aminopeptidase enzymes.[1][2][3]

See also

  • DA-Phen
  • Foslevodopa
  • Melevodopa
  • Etilevodopa
  • O,O′-Diacetyldopamine
  • O,O′-Dipivaloyldopamine
  • Neurotransmitter prodrug

References

  1. 1.0 1.1 1.2 "Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements". Current Topics in Medicinal Chemistry 21 (24): 2157–2169. 2021. doi:10.2174/1568026621666210727163827. PMID 34315372. 
  2. 2.0 2.1 2.2 2.3 "Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies". CNS Drugs 34 (11): 1149–1163. November 2020. doi:10.1007/s40263-020-00769-7. PMID 33146817. 
  3. 3.0 3.1 3.2 3.3 "DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons". CNS Neuroscience & Therapeutics 22 (6): 461–467. June 2016. doi:10.1111/cns.12518. PMID 26861609.